Multiple Sklerozlu Bireylerde ICF Bakış Açısı ile Use-it ve Myoton-3'ün Üst Ekstremiteye Yönelik Klinik Değerlendirme Yöntemleri ile İlişkisinin İncelenmesi

Abstract

The aim of our study was to investigate the relationship between the Use-it system and the Myoton-3 device used to evaluate the upper extremity in individuals with Multiple Sclerosis and clinical assessment methods. A total of 44 individuals with MS, 31 female (70.5%) and 13 male (29.5%) with a mean age of 46.75±9.90 years, were included in the study. Firstly, demographic information of the participants were recorded, then upper extremity motor function was measured using Fugl Meyer Upper Extremity Motor Assessment Scale (FM-UE), grip strength using Jamar Hand Dynamometer, pinch grip strength using Pinchmeter, muscle tone using Modified Ashworth Scale (MAS), position sense using Digital Inclinometer, hand functions and activity level using Nine-Hole Peg Test (DDPT), Purdue Pegboard Manual Dexterity Test (PPEBT), Minnesota Manual Dexterity Test (MEBT), Manual Ability Measure-36 (MAM-36); Participation and quality of life were assessed with Frenchay Activity Index (FAI), Multiple Sclerosis International Quality of Life Questionnaire-54 (MSQOL-54). In addition, biomechanical properties of Biceps Brachii (BB), Flexor Carpi Ulnaris (FCU), Flexor Carpi Radialis (FCR) and Extensor Digitorum (ED) muscles were measured with Myoton-3 device. Global and Local Limitation Maps (GLM and LLM) were created with Use-it. A relationship was found between Use-it GKH total score and FM-ÜE total score, Pinchmeter, DDPT time, PPEBT score, MEBT time, FAI and MSQOL-54 Composite Mental Health score (p<0.05). A relationship was found between muscle tone assessed with Myoton-3 and MAS (p<0.05). These results indicate that Use-it may be an important tool for assessing the position and location of the hand in space during daily living activities in individuals with MS and that the Myoton-3 device may be used as an alternative assessment tool to overcome the limitations of MAS in spasticity assessment.